AstraZeneca delays Galida filing to 2007 LONDON, October 6 (newratings.com) - AstraZeneca (AZN.ISE) has delayed the regulatory approval filing target for its diabetes drug, Galida, from 2006 to 2007, while admitting that its anti-blood clotting drug, Exanta, was unlikely to receive the US 